RxSight (RXST) Total Debt (2020 - 2023)

RxSight's Total Debt history runs 4 years deep, the most recent figure standing at $24.8 million for Q2 2023.

• Quarterly Total Debt fell 40.51% year-over-year to $24.8 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $24.8 million (down 40.51% YoY) and the FY2022 annual result came in at $40.2 million, up 1.03% from the prior year.
• Total Debt was $24.8 million for Q2 2023 at RxSight, down from $40.3 million in the prior quarter.
• Across five years, Total Debt topped out at $41.8 million in Q3 2022 and bottomed at $24.4 million in Q4 2020.
• A 4-year average of $37.2 million and a median of $39.8 million in 2021 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2021 — Total Debt soared 62.96% — and 2023, when it plunged 40.51%.
• RxSight's Total Debt stood at $24.4 million in 2020, then surged by 62.96% to $39.8 million in 2021, then advanced by 1.03% to $40.2 million in 2022, then plunged by 38.25% to $24.8 million in 2023.
• Business Quant data shows RXST's Total Debt at $24.8 million in Q2 2023, $40.3 million in Q1 2023, and $40.2 million in Q4 2022.